From antibiotic resistance to emerging viral threats, the global demand for new medicines is intensifying, yet traditional drug discovery pipelines remain slow and expensive. A new scientific review ...

Syngene International has entered a strategic collaboration with VivaMed BioPharma to advance AI-derived repurposed therapeutic programmes.

In a recently accepted manuscript titled “Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data”, scientists from Insilico ...

And there's more than one way to monetize this technology.

In a landmark development for Indian life sciences and biotechnology, Hyderabad-based SCIINV Biosciences has developed India’s first AI-driven antimicrobial candidate using an advanced ...

When David Fajgenbaum was in medical school, he was diagnosed with an incurable illness called Castleman disease. He was 25 years old when doctors told him “there’s nothing we can do,” and a priest ...

Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.

Algorithms used for consumer predictions are being retooled to help identify which medicines are optimal and may carry hidden risks for patients. Researchers from Monash University used a different ...

Hyderabad-based SCIINV Biosciences has identified a new AI-driven repurposed antibiotic now entering human clinical trials. The breakthrough, backed by Whale Tank Biocatalyst, reduces development time ...

Artificial intelligence (AI) machine learning is becoming an important tool in drug discovery. A new study published on Monday in Nature Machine Intelligence shows how AI deep learning can be used to ...